Katrin Preller

The Two Faces of #PTSD: Fear vs. Emotional Pain. Our new research in Biological Psychiatry @biologicalpsych.bsky.social identifies distinct clinical & neural profiles.

AI says no one reads long papers, so we made an infographic!👇

Full Paper (for the insistents😉): doi.org/10.1016/j.bi...

BBC Radio 4 - Understand, The Trip Tim Hayward looks at the science, culture, history - and future - of psychedelics.

NEW TEN-PART AUDIO SERIES about #PSYCHEDELICS
Out now on BBC Sounds - and other podcast spaces.

Co-written & presented by the beautifully curious @timhayward.bsky.social
Production, sound design and mix by me.

It's been a fascinating and challenging process to get here...

I do hope you'll listen.

The emotional architecture of the psychedelic
brain: If you are interested in #psychedelics and #emotions, take a look at our new paper: authors.elsevier.com/sd/article/S.... With Flora Moujaes, @nathalierieser.bsky.social, Lydia Belinger, Marcus Herdener, & Zarmeen Zahid. Just published in TICS.

🧵 How do psychedelics shape brain activity?

Our new paper presents the largest neuroimaging study of psilocybin to date—revealing how context structures psychedelic brain states.

Title: Psychedelics Align Brain Activity with Context
Paper: lnkd.in/gt-kMR6d

A thread 🧵👇 1/n

Absolutely, there was a lot going on at that time.

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial Despite the promising therapeutic effects of psilocybin, its efficacy in preventing relapse after withdrawal treatment for alcohol use disorder (AUD) …

Above all, this study highlights that more research is needed to find out who is most likely to benefit from psychedelic-assisted therapy and what constitutes the best therapeutic model. For more details, take a look at the publication (open access): www.sciencedirect.com/science/arti....

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial Despite the promising therapeutic effects of psilocybin, its efficacy in preventing relapse after withdrawal treatment for alcohol use disorder (AUD) …

There may be many reasons for this, including the small sample size and the severity of AUD in our population. It is possible that achieving sustained benefits requires a more intensive pharmaco-psychotherapeutic approach than was implemented in this study.

We tested a single dose of psilocybin for relapse prevention in alcohol use disorder. As you may notice, this is not another success story for psychedelic-assisted therapy. Contrary to our hypothesis, we did not find any differences between the psilocybin and placebo group on our primary outcomes.

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial Despite the promising therapeutic effects of psilocybin, its efficacy in preventing relapse after withdrawal treatment for alcohol use disorder (AUD) …

Hi everyone, if you are interested in #psychedelic-assisted therapy, we just published a new study: www.sciencedirect.com/science/arti.... Congratulations to Dr. Nathalie Rieser, who has done a terrific job spearheading this project.

1st National Symposium of the Psychedelic Medicine Section - AFPBN SCHEDULE OF THE DAY Click here to discover the program Click here to register ! Date : June 5, 2025 Location : Paris Brain Institute, 47 boulevard de l’Hôpital, 75013 PARIS The 1st National Symposium ...

📣📣📣 I am very happy to announce the first edition of the National Symposium of the #Psychedelic Medicine Section of the #AFPBN, taking place on Thursday, June 5th, 2025, at the Paris Brain Institute.
www.afpbn.org/1st-national...

🎓 Announcing Dr Katrin Preller! 🎓
@katrinpreller.bsky.social - leading researcher in psychedelic neuropsychopharmacology - will be teaching in @MonashUni’s *Psychedelic Science: Fundamentals to Frontiers* course.
📢 Starts Feb

ENROL: www.monash.edu/psychedelic-science

#PsychedelicEducation

Psilocybin increases emotional empathy in patients with major depression - Molecular Psychiatry Molecular Psychiatry - Psilocybin increases emotional empathy in patients with major depression

Hi everyone, we have published a new paper showing that #psilocybin increases emotional #empathy in patients living with depression for at least two weeks after a single administration. If you are interested in #psychedelics and #social cognition, take a look here: www.nature.com/articles/s41...

#SpecialIssue in the FENS journal, EJN - European Journal of Neuroscience! "New trends in the empirical study of #consciousness: Measures and mechanisms"
doi.org/10.1111/ejn....

image: Nicolas Decat "Reflections of consciousness"
#FENS #EJN
@thomasandrillon.bsky.social @katrinpreller.bsky.social